Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 ...

Anti-CD20 mAbs were originally created to treat B cell proliferative diseases such as non-Hodgkin's lymphoma and chronic ...

Up to half of all people living with Alzheimer's Disease in Ireland remain undiagnosed. Now, a new blood test may have the ...

More information: Richard Willson et al, Development of a rapid antigen-based lateral flow assay for tick-borne spotted fever rickettsioses, PLOS ONE (2025). DOI: 10.1371/journal.pone.0312819 ...

Figure 1. (Left) examples of flexible VaxArray microarray-based assay designs, with 5’CapQ assay schematic highlighted, (Center) a schematic of a single VaxArray microarray slide with 16 ...

tuberculosis. This test, the so-called Molecular Bacterial Load Assay (MBLA), represents a novel innovative tool for monitoring TB treatment. The assay measures M. tuberculosis 16S rRNA ...

Systems immunology methods, including multiomics (notably RNA sequencing transcriptomics), machine learning, and network biology analysis, have the potential to transform the management paradigm ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA ...

27, 2025 /PRNewswire/ -- Partillion Bioscience Corporation ("Partillion"), a life science tools company, announced the opening of pre-orders for its Nanovial Multicell Assay Antibody Discovery Kits.